[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Athletes Foot (Tinea pedis) Treatment Market - Global Outlook and Forecast 2021-2027

April 2021 | 103 pages | ID: AC39D9D7EBF6EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Athletes Foot (Tinea pedis) Treatment in Global, including the following market information:

Global Athletes Foot (Tinea pedis) Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Athletes Foot (Tinea pedis) Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Athletes Foot (Tinea pedis) Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Athletes Foot (Tinea pedis) Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Athletes Foot (Tinea pedis) Treatment Market Segment Percentages, By Type, 2020 (%)
  • Interdigital
  • Erosion Type
  • Blister Type
China Athletes Foot (Tinea pedis) Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Athletes Foot (Tinea pedis) Treatment Market Segment Percentages, By Application, 2020 (%)
  • Children
  • Adult
Global Athletes Foot (Tinea pedis) Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Athletes Foot (Tinea pedis) Treatment Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Athletes Foot (Tinea pedis) Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Athletes Foot (Tinea pedis) Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • Bausch
  • Quinnova Pharmaceuticals (Everett Laboratories)
  • Anacor Pharmaceuticals
  • Cardinal Health
  • Novartis AG
  • Merck
  • Pfizer
  • Medimetriks Pharmaceuticals
  • Medicis Pharmaceutical Corporation
  • Johnson and Johnson
  • Roche
  • Sanofi
  • Teva Pharmaceutical
  • Bayer Healthcare LLC
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Athletes Foot (Tinea pedis) Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Athletes Foot (Tinea pedis) Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ATHLETES FOOT (TINEA PEDIS) TREATMENT OVERALL MARKET SIZE

2.1 Global Athletes Foot (Tinea pedis) Treatment Market Size: 2021 VS 2027
2.2 Global Athletes Foot (Tinea pedis) Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Athletes Foot (Tinea pedis) Treatment Players in Global Market
3.2 Top Global Athletes Foot (Tinea pedis) Treatment Companies Ranked by Revenue
3.3 Global Athletes Foot (Tinea pedis) Treatment Revenue by Companies
3.4 Top 3 and Top 5 Athletes Foot (Tinea pedis) Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Athletes Foot (Tinea pedis) Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Athletes Foot (Tinea pedis) Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Athletes Foot (Tinea pedis) Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Athletes Foot (Tinea pedis) Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Athletes Foot (Tinea pedis) Treatment Market Size Markets, 2021 & 2027
  4.1.2 Interdigital
  4.1.3 Erosion Type
  4.1.4 Blister Type
4.2 By Type - Global Athletes Foot (Tinea pedis) Treatment Revenue & Forecasts
  4.2.1 By Type - Global Athletes Foot (Tinea pedis) Treatment Revenue, 2016-2021
  4.2.2 By Type - Global Athletes Foot (Tinea pedis) Treatment Revenue, 2022-2027
  4.2.3 By Type - Global Athletes Foot (Tinea pedis) Treatment Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Athletes Foot (Tinea pedis) Treatment Market Size, 2021 & 2027
  5.1.2 Children
  5.1.3 Adult
5.2 By Application - Global Athletes Foot (Tinea pedis) Treatment Revenue & Forecasts
  5.2.1 By Application - Global Athletes Foot (Tinea pedis) Treatment Revenue, 2016-2021
  5.2.2 By Application - Global Athletes Foot (Tinea pedis) Treatment Revenue, 2022-2027
  5.2.3 By Application - Global Athletes Foot (Tinea pedis) Treatment Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Athletes Foot (Tinea pedis) Treatment Market Size, 2021 & 2027
6.2 By Region - Global Athletes Foot (Tinea pedis) Treatment Revenue & Forecasts
  6.2.1 By Region - Global Athletes Foot (Tinea pedis) Treatment Revenue, 2016-2021
  6.2.2 By Region - Global Athletes Foot (Tinea pedis) Treatment Revenue, 2022-2027
  6.2.3 By Region - Global Athletes Foot (Tinea pedis) Treatment Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Athletes Foot (Tinea pedis) Treatment Revenue, 2016-2027
  6.3.2 US Athletes Foot (Tinea pedis) Treatment Market Size, 2016-2027
  6.3.3 Canada Athletes Foot (Tinea pedis) Treatment Market Size, 2016-2027
  6.3.4 Mexico Athletes Foot (Tinea pedis) Treatment Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Athletes Foot (Tinea pedis) Treatment Revenue, 2016-2027
  6.4.2 Germany Athletes Foot (Tinea pedis) Treatment Market Size, 2016-2027
  6.4.3 France Athletes Foot (Tinea pedis) Treatment Market Size, 2016-2027
  6.4.4 U.K. Athletes Foot (Tinea pedis) Treatment Market Size, 2016-2027
  6.4.5 Italy Athletes Foot (Tinea pedis) Treatment Market Size, 2016-2027
  6.4.6 Russia Athletes Foot (Tinea pedis) Treatment Market Size, 2016-2027
  6.4.7 Nordic Countries Athletes Foot (Tinea pedis) Treatment Market Size, 2016-2027
  6.4.8 Benelux Athletes Foot (Tinea pedis) Treatment Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Athletes Foot (Tinea pedis) Treatment Revenue, 2016-2027
  6.5.2 China Athletes Foot (Tinea pedis) Treatment Market Size, 2016-2027
  6.5.3 Japan Athletes Foot (Tinea pedis) Treatment Market Size, 2016-2027
  6.5.4 South Korea Athletes Foot (Tinea pedis) Treatment Market Size, 2016-2027
  6.5.5 Southeast Asia Athletes Foot (Tinea pedis) Treatment Market Size, 2016-2027
  6.5.6 India Athletes Foot (Tinea pedis) Treatment Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Athletes Foot (Tinea pedis) Treatment Revenue, 2016-2027
  6.6.2 Brazil Athletes Foot (Tinea pedis) Treatment Market Size, 2016-2027
  6.6.3 Argentina Athletes Foot (Tinea pedis) Treatment Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Athletes Foot (Tinea pedis) Treatment Revenue, 2016-2027
  6.7.2 Turkey Athletes Foot (Tinea pedis) Treatment Market Size, 2016-2027
  6.7.3 Israel Athletes Foot (Tinea pedis) Treatment Market Size, 2016-2027
  6.7.4 Saudi Arabia Athletes Foot (Tinea pedis) Treatment Market Size, 2016-2027
  6.7.5 UAE Athletes Foot (Tinea pedis) Treatment Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Bausch
  7.1.1 Bausch Corporate Summary
  7.1.2 Bausch Business Overview
  7.1.3 Bausch Athletes Foot (Tinea pedis) Treatment Major Product Offerings
  7.1.4 Bausch Athletes Foot (Tinea pedis) Treatment Revenue in Global (2016-2021)
  7.1.5 Bausch Key News
7.2 Quinnova Pharmaceuticals (Everett Laboratories)
  7.2.1 Quinnova Pharmaceuticals (Everett Laboratories) Corporate Summary
  7.2.2 Quinnova Pharmaceuticals (Everett Laboratories) Business Overview
  7.2.3 Quinnova Pharmaceuticals (Everett Laboratories) Athletes Foot (Tinea pedis) Treatment Major Product Offerings
  7.2.4 Quinnova Pharmaceuticals (Everett Laboratories) Athletes Foot (Tinea pedis) Treatment Revenue in Global (2016-2021)
  7.2.5 Quinnova Pharmaceuticals (Everett Laboratories) Key News
7.3 Anacor Pharmaceuticals
  7.3.1 Anacor Pharmaceuticals Corporate Summary
  7.3.2 Anacor Pharmaceuticals Business Overview
  7.3.3 Anacor Pharmaceuticals Athletes Foot (Tinea pedis) Treatment Major Product Offerings
  7.3.4 Anacor Pharmaceuticals Athletes Foot (Tinea pedis) Treatment Revenue in Global (2016-2021)
  7.3.5 Anacor Pharmaceuticals Key News
7.4 Cardinal Health
  7.4.1 Cardinal Health Corporate Summary
  7.4.2 Cardinal Health Business Overview
  7.4.3 Cardinal Health Athletes Foot (Tinea pedis) Treatment Major Product Offerings
  7.4.4 Cardinal Health Athletes Foot (Tinea pedis) Treatment Revenue in Global (2016-2021)
  7.4.5 Cardinal Health Key News
7.5 Novartis AG
  7.5.1 Novartis AG Corporate Summary
  7.5.2 Novartis AG Business Overview
  7.5.3 Novartis AG Athletes Foot (Tinea pedis) Treatment Major Product Offerings
  7.5.4 Novartis AG Athletes Foot (Tinea pedis) Treatment Revenue in Global (2016-2021)
  7.5.5 Novartis AG Key News
7.6 Merck
  7.6.1 Merck Corporate Summary
  7.6.2 Merck Business Overview
  7.6.3 Merck Athletes Foot (Tinea pedis) Treatment Major Product Offerings
  7.6.4 Merck Athletes Foot (Tinea pedis) Treatment Revenue in Global (2016-2021)
  7.6.5 Merck Key News
7.7 Pfizer
  7.7.1 Pfizer Corporate Summary
  7.7.2 Pfizer Business Overview
  7.7.3 Pfizer Athletes Foot (Tinea pedis) Treatment Major Product Offerings
  7.4.4 Pfizer Athletes Foot (Tinea pedis) Treatment Revenue in Global (2016-2021)
  7.7.5 Pfizer Key News
7.8 Medimetriks Pharmaceuticals
  7.8.1 Medimetriks Pharmaceuticals Corporate Summary
  7.8.2 Medimetriks Pharmaceuticals Business Overview
  7.8.3 Medimetriks Pharmaceuticals Athletes Foot (Tinea pedis) Treatment Major Product Offerings
  7.8.4 Medimetriks Pharmaceuticals Athletes Foot (Tinea pedis) Treatment Revenue in Global (2016-2021)
  7.8.5 Medimetriks Pharmaceuticals Key News
7.9 Medicis Pharmaceutical Corporation
  7.9.1 Medicis Pharmaceutical Corporation Corporate Summary
  7.9.2 Medicis Pharmaceutical Corporation Business Overview
  7.9.3 Medicis Pharmaceutical Corporation Athletes Foot (Tinea pedis) Treatment Major Product Offerings
  7.9.4 Medicis Pharmaceutical Corporation Athletes Foot (Tinea pedis) Treatment Revenue in Global (2016-2021)
  7.9.5 Medicis Pharmaceutical Corporation Key News
7.10 Johnson and Johnson
  7.10.1 Johnson and Johnson Corporate Summary
  7.10.2 Johnson and Johnson Business Overview
  7.10.3 Johnson and Johnson Athletes Foot (Tinea pedis) Treatment Major Product Offerings
  7.10.4 Johnson and Johnson Athletes Foot (Tinea pedis) Treatment Revenue in Global (2016-2021)
  7.10.5 Johnson and Johnson Key News
7.11 Roche
  7.11.1 Roche Corporate Summary
  7.11.2 Roche Business Overview
  7.11.3 Roche Athletes Foot (Tinea pedis) Treatment Major Product Offerings
  7.11.4 Roche Athletes Foot (Tinea pedis) Treatment Revenue in Global (2016-2021)
  7.11.5 Roche Key News
7.12 Sanofi
  7.12.1 Sanofi Corporate Summary
  7.12.2 Sanofi Business Overview
  7.12.3 Sanofi Athletes Foot (Tinea pedis) Treatment Major Product Offerings
  7.12.4 Sanofi Athletes Foot (Tinea pedis) Treatment Revenue in Global (2016-2021)
  7.12.5 Sanofi Key News
7.13 Teva Pharmaceutical
  7.13.1 Teva Pharmaceutical Corporate Summary
  7.13.2 Teva Pharmaceutical Business Overview
  7.13.3 Teva Pharmaceutical Athletes Foot (Tinea pedis) Treatment Major Product Offerings
  7.13.4 Teva Pharmaceutical Athletes Foot (Tinea pedis) Treatment Revenue in Global (2016-2021)
  7.13.5 Teva Pharmaceutical Key News
7.14 Bayer Healthcare LLC
  7.14.1 Bayer Healthcare LLC Corporate Summary
  7.14.2 Bayer Healthcare LLC Business Overview
  7.14.3 Bayer Healthcare LLC Athletes Foot (Tinea pedis) Treatment Major Product Offerings
  7.14.4 Bayer Healthcare LLC Athletes Foot (Tinea pedis) Treatment Revenue in Global (2016-2021)
  7.14.5 Bayer Healthcare LLC Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Athletes Foot (Tinea pedis) Treatment Market Opportunities & Trends in Global Market
Table 2. Athletes Foot (Tinea pedis) Treatment Market Drivers in Global Market
Table 3. Athletes Foot (Tinea pedis) Treatment Market Restraints in Global Market
Table 4. Key Players of Athletes Foot (Tinea pedis) Treatment in Global Market
Table 5. Top Athletes Foot (Tinea pedis) Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Athletes Foot (Tinea pedis) Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Athletes Foot (Tinea pedis) Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Athletes Foot (Tinea pedis) Treatment Product Type
Table 9. List of Global Tier 1 Athletes Foot (Tinea pedis) Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Athletes Foot (Tinea pedis) Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Athletes Foot (Tinea pedis) Treatment Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Athletes Foot (Tinea pedis) Treatment Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Athletes Foot (Tinea pedis) Treatment Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Athletes Foot (Tinea pedis) Treatment Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Athletes Foot (Tinea pedis) Treatment Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Athletes Foot (Tinea pedis) Treatment Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2022-2027
Table 30. Bausch Corporate Summary
Table 31. Bausch Athletes Foot (Tinea pedis) Treatment Product Offerings
Table 32. Bausch Athletes Foot (Tinea pedis) Treatment Revenue (US$, Mn), (2016-2021)
Table 33. Quinnova Pharmaceuticals (Everett Laboratories) Corporate Summary
Table 34. Quinnova Pharmaceuticals (Everett Laboratories) Athletes Foot (Tinea pedis) Treatment Product Offerings
Table 35. Quinnova Pharmaceuticals (Everett Laboratories) Athletes Foot (Tinea pedis) Treatment Revenue (US$, Mn), (2016-2021)
Table 36. Anacor Pharmaceuticals Corporate Summary
Table 37. Anacor Pharmaceuticals Athletes Foot (Tinea pedis) Treatment Product Offerings
Table 38. Anacor Pharmaceuticals Athletes Foot (Tinea pedis) Treatment Revenue (US$, Mn), (2016-2021)
Table 39. Cardinal Health Corporate Summary
Table 40. Cardinal Health Athletes Foot (Tinea pedis) Treatment Product Offerings
Table 41. Cardinal Health Athletes Foot (Tinea pedis) Treatment Revenue (US$, Mn), (2016-2021)
Table 42. Novartis AG Corporate Summary
Table 43. Novartis AG Athletes Foot (Tinea pedis) Treatment Product Offerings
Table 44. Novartis AG Athletes Foot (Tinea pedis) Treatment Revenue (US$, Mn), (2016-2021)
Table 45. Merck Corporate Summary
Table 46. Merck Athletes Foot (Tinea pedis) Treatment Product Offerings
Table 47. Merck Athletes Foot (Tinea pedis) Treatment Revenue (US$, Mn), (2016-2021)
Table 48. Pfizer Corporate Summary
Table 49. Pfizer Athletes Foot (Tinea pedis) Treatment Product Offerings
Table 50. Pfizer Athletes Foot (Tinea pedis) Treatment Revenue (US$, Mn), (2016-2021)
Table 51. Medimetriks Pharmaceuticals Corporate Summary
Table 52. Medimetriks Pharmaceuticals Athletes Foot (Tinea pedis) Treatment Product Offerings
Table 53. Medimetriks Pharmaceuticals Athletes Foot (Tinea pedis) Treatment Revenue (US$, Mn), (2016-2021)
Table 54. Medicis Pharmaceutical Corporation Corporate Summary
Table 55. Medicis Pharmaceutical Corporation Athletes Foot (Tinea pedis) Treatment Product Offerings
Table 56. Medicis Pharmaceutical Corporation Athletes Foot (Tinea pedis) Treatment Revenue (US$, Mn), (2016-2021)
Table 57. Johnson and Johnson Corporate Summary
Table 58. Johnson and Johnson Athletes Foot (Tinea pedis) Treatment Product Offerings
Table 59. Johnson and Johnson Athletes Foot (Tinea pedis) Treatment Revenue (US$, Mn), (2016-2021)
Table 60. Roche Corporate Summary
Table 61. Roche Athletes Foot (Tinea pedis) Treatment Product Offerings
Table 62. Roche Athletes Foot (Tinea pedis) Treatment Revenue (US$, Mn), (2016-2021)
Table 63. Sanofi Corporate Summary
Table 64. Sanofi Athletes Foot (Tinea pedis) Treatment Product Offerings
Table 65. Sanofi Athletes Foot (Tinea pedis) Treatment Revenue (US$, Mn), (2016-2021)
Table 66. Teva Pharmaceutical Corporate Summary
Table 67. Teva Pharmaceutical Athletes Foot (Tinea pedis) Treatment Product Offerings
Table 68. Teva Pharmaceutical Athletes Foot (Tinea pedis) Treatment Revenue (US$, Mn), (2016-2021)
Table 69. Bayer Healthcare LLC Corporate Summary
Table 70. Bayer Healthcare LLC Athletes Foot (Tinea pedis) Treatment Product Offerings
Table 71. Bayer Healthcare LLC Athletes Foot (Tinea pedis) Treatment Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Athletes Foot (Tinea pedis) Treatment Segment by Type
Figure 2. Athletes Foot (Tinea pedis) Treatment Segment by Application
Figure 3. Global Athletes Foot (Tinea pedis) Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Athletes Foot (Tinea pedis) Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Athletes Foot (Tinea pedis) Treatment Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Athletes Foot (Tinea pedis) Treatment Revenue in 2020
Figure 8. By Type - Global Athletes Foot (Tinea pedis) Treatment Revenue Market Share, 2016-2027
Figure 9. By Application - Global Athletes Foot (Tinea pedis) Treatment Revenue Market Share, 2016-2027
Figure 10. By Region - Global Athletes Foot (Tinea pedis) Treatment Revenue Market Share, 2016-2027
Figure 11. By Country - North America Athletes Foot (Tinea pedis) Treatment Revenue Market Share, 2016-2027
Figure 12. US Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Athletes Foot (Tinea pedis) Treatment Revenue Market Share, 2016-2027
Figure 16. Germany Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2016-2027
Figure 17. France Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Athletes Foot (Tinea pedis) Treatment Revenue Market Share, 2016-2027
Figure 24. China Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2016-2027
Figure 28. India Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Athletes Foot (Tinea pedis) Treatment Revenue Market Share, 2016-2027
Figure 30. Brazil Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Athletes Foot (Tinea pedis) Treatment Revenue Market Share, 2016-2027
Figure 33. Turkey Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Athletes Foot (Tinea pedis) Treatment Revenue, (US$, Mn), 2016-2027
Figure 37. Bausch Athletes Foot (Tinea pedis) Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Quinnova Pharmaceuticals (Everett Laboratories) Athletes Foot (Tinea pedis) Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Anacor Pharmaceuticals Athletes Foot (Tinea pedis) Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Cardinal Health Athletes Foot (Tinea pedis) Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Novartis AG Athletes Foot (Tinea pedis) Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Merck Athletes Foot (Tinea pedis) Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Pfizer Athletes Foot (Tinea pedis) Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Medimetriks Pharmaceuticals Athletes Foot (Tinea pedis) Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Medicis Pharmaceutical Corporation Athletes Foot (Tinea pedis) Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Johnson and Johnson Athletes Foot (Tinea pedis) Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Roche Athletes Foot (Tinea pedis) Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Sanofi Athletes Foot (Tinea pedis) Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Teva Pharmaceutical Athletes Foot (Tinea pedis) Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications